To confirm the extensive adaptability of down-regulation of TXNDC5 expression to SERPINF1 and TRAF1 expression in the tumorigenic process, Caski and C-33A cervical tumor cells were cultured and transfected with anti-TXNDC5 siRNA. The gene discussed is TRAF1; the disease is uterine cervix neoplasm.